CSL362 potently and specifically depletes pDCs <i>in</i><i>vitro</i> and ablates SLE-immune complex-induced IFN responses.

Monaghan, Katherine A; Hoi, Alberta; Gamell, Cristina; Tai, Tsin Yee; Linggi, Bryan; Jordan, Jarrat; Cesaroni, Matteo; Sato, Takahiro; Ng, Milica; Oon, Shereen; Benson, Jacqueline; Wicks, Ian; Morand, Eric; Wilson, Nicholas

CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses.

Monaghan, Katherine A; Hoi, Alberta; Gamell, Cristina; Tai, Tsin Yee; Linggi, Bryan; Jordan, Jarrat; Cesaroni, Matteo; Sato, Takahiro; Ng, Milica; Oon, Shereen; Benson, Jacqueline; Wicks, Ian; Morand, Eric; Wilson, Nicholas.

Afiliação

Monaghan KA; Research and Development, CSL Limited, Melbourne, VIC 3010, Australia.
Hoi A; Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Melbourne, VIC 3168, Australia.
Gamell C; Monash Health, Clayton, VIC 3168, Australia.
Tai TY; Research and Development, CSL Limited, Melbourne, VIC 3010, Australia.
Linggi B; Research and Development, CSL Limited, Melbourne, VIC 3010, Australia.
Jordan J; Janssen Research and Development LLC, Spring House, PA 19477, USA.
Cesaroni M; Janssen Research and Development LLC, Spring House, PA 19477, USA.
Sato T; Janssen Research and Development LLC, Spring House, PA 19477, USA.
Ng M; Janssen Research and Development LLC, Spring House, PA 19477, USA.
Oon S; Research and Development, CSL Limited, Melbourne, VIC 3010, Australia.
Benson J; The Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia.
Wicks I; The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
Morand E; The University of Melbourne Parkville, Parkville, VIC 3010, Australia.
Wilson N; Janssen Research and Development LLC, Spring House, PA 19477, USA.